Literature DB >> 24371746

Splenectomy as an effective debulking therapy for disseminated mould infection in acute myeloid leukaemia following adjuvant therapy with interferon gamma and liposomal amphotericin.

Anne-Louise Latif1, Chrsitina Harper2, Ian Macdonald1, Anne Morrison1.   

Abstract

Invasive fungal infection is a major cause of morbidity and mortality in patients receiving treatment for Acute Myeloid Leukaemia (AML). Herein, we report a case of a 21 year old woman with an extremely resistant Fusarium species that responded to the addition of interferon gamma to her medical therapy, subsequently allowing definitive debulking surgery of her invasive Fusarium infection to be undertaken.

Entities:  

Keywords:  Acute myeloid leukaemia; Fusarium solani; Interferon gamma

Year:  2012        PMID： 24371746      PMCID： PMC3854636          DOI： 10.1016/j.mmcr.2012.08.005

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN： 2211-7539


  13 in total

Review 1.  Interferon- gamma as an antifungal.

Authors:  David A Stevens; Elmer Brummer; Karl V Clemons
Journal:  J Infect Dis       Date:  2006-09-15       Impact factor: 5.226

2.  Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients.

Authors:  D Armstrong-James; I A Teo; S Shrivastava; M A Petrou; D Taube; A Dorling; S Shaunak
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

Review 3.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 4.  Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia.

Authors:  R Swords; C Freeman; F Giles
Journal:  Leukemia       Date:  2012-04-27       Impact factor: 11.528

5.  Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis.

Authors:  Christopher A Duplessis; Drake Tilley; Mary Bavaro; Braden Hale; Steven M Holland
Journal:  J Infect       Date:  2011-07-20       Impact factor: 6.072

Review 6.  Emerging fungal diseases.

Authors:  Marcio Nucci; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2005-07-11       Impact factor: 9.079

Review 7.  The challenge of managing fusariosis.

Authors:  Maged Muhammed; Jeffrey J Coleman; Herman A Carneiro; Eleftherios Mylonakis
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

8.  Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions.

Authors:  G Illerhaus; K Wirth; A Dwenger; C F Waller; A Garbe; V Brass; H Lang; W Lange
Journal:  Ann Hematol       Date:  2002-04-03       Impact factor: 3.673

Review 9.  Fungal infections in leukemia patients: how do we prevent and treat them?

Authors:  Konstantinos Leventakos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

10.  In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.

Authors:  Susana Córdoba; Laura Rodero; Walter Vivot; Rubén Abrantes; Graciela Davel; Roxana G Vitale
Journal:  Int J Antimicrob Agents       Date:  2007-12-03       Impact factor: 5.283
View more
  1 in total

1.  Skin and subcutaneous mycoses in tilapia (Oreochromis niloticus) caused by Fusarium oxysporum in coinfection with Aeromonas hydrophila.

Authors:  M Teresa Cutuli; Alicia Gibello; Antonio Rodriguez-Bertos; M Mar Blanco; Morris Villarroel; Alejandra Giraldo; Josep Guarro
Journal:  Med Mycol Case Rep       Date:  2015-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.